37 min ago | The Courier-Journal
Her face flushed, Rosemary Lamont sat on the gym floor one recent afternoon, listening to her trainer's impassioned commands.
The number of women ringing the breast cancer helpline tripled following Angelina Jolie's decision to undergo a double mastectomy.
CCF child ambassador Kelcey Roberts with Truebliss band members Megan Alatini and Erikia Takacs, and school children from Bucklands Beach Intermediate.
As the season of bare skin and scorching sun draws near, you - like so many other people - may find yourself scratching your head over sunscreen.
Researchers were able to discover a chemical that made naked mole rats resistant to cancer.
Lab studies show the skin cells of the naked mole-rat are high in a natural sugary substance that stops tumours developing.
A mechanism that cells use to group together and move around the body- called "chase and run"- has been described for the first time by scientists at UCL .
Maggie Luck and her husband, Richard, on the summit of Mount Alice in Rocky Mountain National Park in August 2011.
In patients with these mutations, PARP inhibitors, which are currently in clinical trials, have shown encouraging results that make them a new option for personalised cancer treatment, an alternative to standard chemotherapy.
A Canadian-U.S. team of researchers has developed a new "sharp-shooter" drug they hope will be a breakthrough in treating several types of cancer.
TBBCF needs volunteers for two leadership positions to support the 2013 Walk Across Southeastern CT that takes place on October 5. Both positions must be available on Walk day.
Medical card patients, who have undergone breast cancer treatment in hospital, may have to pay the cost of their GP cancer care follow-up.
A Spokane, Washington-area woman says she was forced to quit her job as a hair salon supervisor after her boss told her to cover her shaved head while at work.
Twenty-one female news anchors in our area are joining up with supporters and survivors Thursday, June 27 to raise funds for the Howard University Cancer Center.
Johnson & Johnson said it would pay up to $1 billion for Aragon Pharmaceuticals and its experimental drugs for prostate cancer, to bolster J&J's role in the field after it acquired another experimental prostate-cancer treatment four years ago that has become a leading brand.
Gone are the days when a sunscreen could label itself waterproof or sweatproof or claim it provided instant or sunblock protection.